CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Acuitas Therapeutics, Inc. v. CureVac SE

3:23-cv-00764

Overview

Case Number 3:23-cv-00764
Filing Date 2023-11-13
Status Terminated
Termination Date 2023-11-28
Court District Court, E.D. Virginia (vaed)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:256 Patent Non-Infringement
Jury Demand None

Parties

Defendant

CureVac SE NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Barbara Mui NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Robert William McFarland

McGuireWoods LLP

Tel: +1 (757) 640-3700
Fax: +1 (757) 640-3701

101 W Main St, Suite 9000

Paulo Lin NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Robert William McFarland

McGuireWoods LLP

Tel: +1 (757) 640-3700
Fax: +1 (757) 640-3701

101 W Main St, Suite 9000

Ying Tam NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Robert William McFarland

McGuireWoods LLP

Tel: +1 (757) 640-3700
Fax: +1 (757) 640-3701

101 W Main St, Suite 9000

Michael Hope NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Robert William McFarland

McGuireWoods LLP

Tel: +1 (757) 640-3700
Fax: +1 (757) 640-3701

101 W Main St, Suite 9000

Acuitas Therapeutics, Inc. Operating Company

Represented By

1 Attorneys Listed

Robert William McFarland

McGuireWoods LLP

Tel: +1 (757) 640-3700
Fax: +1 (757) 640-3701

101 W Main St, Suite 9000

Court & Judges

Court

District Court, E.D. Virginia (vaed)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 7 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (7): πŸ‡ͺπŸ‡Ί Europe πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US11241493
Coronavirus vaccine
Filed: 2021-04-15
Issued: 2022-02-08
Active (14.4 yrs remaining)
Expires: 2041-04-15
US11471525
Coronavirus vaccine
Filed: 2021-12-09
Issued: 2022-10-18
Active (15.0 yrs remaining)
Expires: 2041-12-09
US11576966
Coronavirus vaccine
Filed: 2021-11-15
Issued: 2023-02-14
Active (15.0 yrs remaining)
Expires: 2041-11-15
US11596686
Coronavirus vaccine
Filed: 2022-08-09
Issued: 2023-03-07
Active (14.2 yrs remaining)
Expires: 2041-02-03

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

1

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Motion to Transfer Venue (28 U.S.C. Β§ 1404) 1

Key Dispositive Motions & Rulings

Motion to Transfer Venue (28 U.S.C. Β§ 1404) Pending / Under Review
MOTION to Transfer Case and Unapposed Memo in Support by Acuitas Therapeutics, Inc., Michael Hope, Paulo Lin, Barbara Mui, Ying Tam. (McFarland, Robert) (Entere...
Entry #10 • 2023-11-28 Document →

Docket Entries

(19 total)
Pleading / Complaint

Complaint Public Version ( Filing fee $ 402, receipt number AVAEDC-9216699.), filed by Paulo Lin, Acuitas Therapeutics, Inc., Ying Tam, Barbara Mui. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit Ex. A- US11241493, # 3 Exhibit Ex. B- US11471525, # 4 Exhibit Ex. C - US11576966, # 5 Exhibit Ex. D - US11596686)(McFarland, Robert) (Entered: 11/13/2023)

Entry #1 • 2023-11-13
1
Pleading / Complaint

Complaint Public Version ( Filing fee $ 402, receipt number AVAEDC-9216699.), filed by Paulo Lin, Acuitas Therapeutics, Inc., Ying Tam, Barbara Mui. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit Ex. A- US11241493, # 3 Exhibit Ex. B- US11471525, # 4 Exhibit Ex. C - US11576966, # 5 Exhibit Ex. D - US11596686)(McFarland, Robert) (Entered: 11/13/2023)

Entry #1 • 2023-11-13
2
Pleading / Complaint

Complaint Public Version ( Filing fee $ 402, receipt number AVAEDC-9216699.), filed by Paulo Lin, Acuitas Therapeutics, Inc., Ying Tam, Barbara Mui. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit Ex. A- US11241493, # 3 Exhibit Ex. B- US11471525, # 4 Exhibit Ex. C - US11576966, # 5 Exhibit Ex. D - US11596686)(McFarland, Robert) (Entered: 11/13/2023)

Entry #1 • 2023-11-13
2
Pleading / Complaint

Complaint Public Version ( Filing fee $ 402, receipt number AVAEDC-9216699.), filed by Paulo Lin, Acuitas Therapeutics, Inc., Ying Tam, Barbara Mui. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit Ex. A- US11241493, # 3 Exhibit Ex. B- US11471525, # 4 Exhibit Ex. C - US11576966, # 5 Exhibit Ex. D - US11596686)(McFarland, Robert) (Entered: 11/13/2023)

Entry #1 • 2023-11-13
2
Pleading / Complaint

Complaint Public Version ( Filing fee $ 402, receipt number AVAEDC-9216699.), filed by Paulo Lin, Acuitas Therapeutics, Inc., Ying Tam, Barbara Mui. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit Ex. A- US11241493, # 3 Exhibit Ex. B- US11471525, # 4 Exhibit Ex. C - US11576966, # 5 Exhibit Ex. D - US11596686)(McFarland, Robert) (Entered: 11/13/2023)

Entry #1 • 2023-11-13
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc